Free U.S. shipping on orders of $20.00 or more
April Kirkendoll
ISBN 0-9667784-1-3
LCCN 2003098427
$16.95,Trade paperback, 224 pages
The End of Cancer delves into the biology of cancer, and several chapters are devoted to the details of how a nontoxic new therapy (now trademarked as “Apatone®”) works against cancers. Apatone takes advantage of cancer’s main peculiarity: its altered metabolism and deficiency of certain enzymes. The metabolic defects that separate a cancer cell from a normal cell are both its strength and its weakness, and understanding how and why Apatone works helps us to learn about cancer from the inside out.
The End of Cancer:
Seeking A New Understanding To Defeat The Enemy Within
The End of Cancer is not about “alternative medicine”.
It is a new way of viewing established facts of cancer biology, which may lead to improved methods of treating cancers.
Apatone® has been issued an Investigational Drug Number
and is currently undergoing FDA trials.
For more information about Apatone® therapy and research,
please visit: www.ic-medtech.com
